Potential mechanisms of the effect of the variants of both genes (PPAR-γ, PGC-1α) may be speculated to affect serum/tissue levels of both proteins, other risk factors (i.e., obesity and obesity indexes) or other effects (i.e., lipid status). The gene discussed is PPARGC1A; the disease is obesity disorder.